Press Release

Tianda Pharmaceuticals Annual Results 2022
Jun 30, 2022 11:40 JST

Tianda Pharmaceuticals Limited (Tianda Pharmaceuticals or the Group, stock code: 0455.HK) is pleased to announce its annual results for the year ended 31 March 2022. During the Reporting Period, the Group's business attained further development as revenue reached HK$510.0 million for the Current Financial Year, representing an increase of 7.5% compared to last year.
More info..

Tianda Pharma Interim Results 2021 Nov 26, 2021 18:40 JST Tianda Pharmaceuticals Limited (Tianda Pharma or the Group, stock code: 0455.HK) is pleased to announce its interim results for the six months ended 30 September 2021 (the "Reporting Period"). More info..

The third TDMall in the world opened in Sydney, Australia
Mar 16, 2021 19:52 JST

TDMall (Group) Limited, a subsidiary of Tianda Pharmaceuticals Limited (listed on the main board of the Hong Kong Stock Exchange: 00455) has invested in the establishment of modern-style Chinese medicine clinic - TDMall, and grandly opened its third TDMall in the world, TDMall (Sydney), on 14 March in Macquarie Park, Sydney, Australia.
More info..

Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout
Mar 04, 2021 19:43 JST

Tianda Pharmaceuticals Limited (0455.HK) is pleased to announce that its wholly-owned subsidiary, Tianda Pharmaceutical (Zhuhai) Co., Ltd., has entered into a Technology Transfer Contract with Heilongjiang Jiren Pharmaceutical Co., Ltd. to acquire the latter's whole technology ownership and all the intellectual rights in Xiaoer Qingre Zhike Granule, National medicine registration approval number: Z20033093).
More info..

Tianda Pharmaceuticals acquires Yeung & Young Medicare and Qi's Living, establishing long-term cooperation
Oct 06, 2020 11:00 JST

Tianda Pharmaceuticals Ltd (HKG:0455) is pleased to announce its wholly-owned subsidiary TDMall (Hong Kong) Ltd (TDMall HK) has acquired 50.1% equity interests in both Yeung & Young Medicare Centre Ltd (Yeung & Young) and Qi's Living Company Ltd (Qi's Living), for a total consideration of HK$25 million.
More info..

HK Main-Board Listed Tianda Pharmaceuticals (00455.HK) Promising Outlook for Growth
Jul 10, 2020 15:26 JST

With the successive introduction of the "Opinions on Facilitating the Inheritance, Innovation and Development of Traditional Chinese Medicine (TCM)" in certain provinces in mainland China and the "Regulations on Traditional Chinese Medicine" proposed by the Beijing municipality (Drafted Regulations on TCM for Public Opinions), the TCM industry has embarked on a rapid development.
More info..